查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1663515

CRISPR 和 Cas 基因市場，按產品、按應用、按最終用戶、按國家和地區 - 2025 年至 2032 年全球行業分析、市場規模、市場佔有率和預測

CRISPR and Cas Gene Market, By Product, By Application, By End-User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 303 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

報告重點

2024 年 CRISPR 和 Cas 基因市場規模價值為 48.9943 億美元，2025 年至 2032 年的複合年成長率為 16.90%。

CRISPR 和 Cas 基因市場-市場動態

醫療保健和農業領域對精準基因編輯工具的需求不斷成長

由於 CRISPR-Cas 系統等精準基因編輯工具的變革潛力和成本效益，醫療保健和農業領域對其的需求正在激增。在醫療保健領域，CRISPR 透過直接糾正致病突變實現了對遺傳疾病的突破性治療。例如，它在治療鐮狀細胞性貧血和BETA-地中海貧血方面已顯示出良好的效果。此外，該技術在癌症免疫治療中至關重要，其中工程化 T 細胞可以靶向特定的腫瘤細胞，從而推動個人化醫療的發展。全球遺傳疾病的增多影響了數百萬人，這是在治療研究中採用 CRISPR 技術的關鍵驅動力。據世界衛生組織 (WHO) 稱，大約 10,000 種單基因疾病可以透過基因編輯的進步來治療。在農業領域，CRISPR 正在重新定義作物工程，使科學家能夠開發抗蟲、耐旱和營養豐富的作物，以應對糧食不安全問題。它透過減少對化學農藥和化肥的依賴來支持永續農業。美國農業部（USDA）在2023年報告稱，基因編輯作物可以在未來十年內將糧食產量提高高達30％，強調了該技術解決全球農業挑戰的潛力。與 ZFN 和 TALEN 等舊技術相比，CRISPR 在這些領域的應用日益廣泛，這得益於它的精確性、效率和經濟性，從而改變了醫藥和食品生產領域的格局。

CRISPR 和 Cas 基因市場 - 關鍵見解

  • 根據我們的研究分析師的分析，預測期內（2025-2032 年），全球市場預計年複合成長率約為 16.90%
  • 根據產品細分，預計 CRISPR 產品將在 2024 年佔據最大市場佔有率
  • 根據最終用戶細分，製藥和生物技術公司是 2024 年的領先細分市場
  • 從地區來看，北美是 2024 年最大的收入來源

CRISPR 和 Cas 基因市場-細分分析：

全球 CRISPR 和 Cas 基因市場根據產品、應用、最終用戶和地區進行細分。

根據產品，市場分為兩類：CRISPR 產品和 CRISPR 服務。 CRISPR 產品因其在基因編輯、研究和治療開發中的廣泛應用而佔據市場主導地位，具有無與倫比的精度和效率。使用者友善試劑盒、試劑和先進的 Cas 蛋白的出現推動了醫療保健、農業和生物技術產業的快速應用。

根據最終用戶，市場分為三類：製藥和生物技術公司、學術和研究機構以及合約研究組織。製藥和生物技術公司在藥物發現、基因疾病治療和個人化醫療開發的基因編輯技術方面進行了大量投資，從而佔據了市場主導地位。他們強大的研究基礎設施和對臨床試驗的關注加速了基於 CRISPR 的創新解決方案的商業化，推動了市場成長。

CRISPR 和 Cas 基因市場-地理洞察：

CRISPR 和 Cas 基因市場表現出明顯的區域差異，這是由技術進步、研究資金、監管框架和市場採用方面的差異造成的。北美引領全球市場，這歸功於對基因編輯技術的大量投資、強勁的生物技術產業以及政府的支持政策。美國尤其佔據主導地位，因為它開展了廣泛的研究計劃，並且領先的製藥公司和研究機構之間開展了合作。根據美國國立衛生研究院（NIH）介紹，近年來美國政府為CRISPR相關研究計畫撥款超過10億美元。由於強大的學術研究基礎設施和 CRISPR 技術在治療應用中的日益普及，歐洲佔據著突出的市場佔有率。德國、英國和法國等國家處於 CRISPR 創新的前沿，尤其是在農業生物技術和精準醫療領域。然而，圍繞基因改造的監管限制仍然是一個挑戰。亞太地區正經歷快速成長，主要得益於中國、日本和韓國等國家生物技術產業的擴張。中國已成為主要參與者，積極投資基因編輯研究和臨床應用，特別是在農業和疾病治療領域。該地區對食品安全和個人化醫療的日益關注進一步加速了需求。在農業進步和醫療保健現代化的推動下，拉丁美洲和中東及非洲的新興市場正逐步採用 CRISPR 技術。

CRISPR 與 Cas 基因市場-競爭格局：

CRISPR 和 Cas 基因市場競爭激烈，老牌企業和新興生物技術公司齊聚一堂，推動各類應用的創新。市場上的公司正專注於開發先進的基於 CRISPR 的產品，例如基因編輯試劑盒、試劑和 CRISPR 相關服務，以滿足製藥、生物技術和農業領域日益成長的需求。這些公司投入巨資進行研發，以提高 CRISPR 技術的精確度、效率和可擴展性，這對於成功商業化至關重要。競爭格局的特點是策略夥伴關係、協作和收購，旨在擴大產品組合和市場範圍。主要參與者也與學術機構和研究組織建立聯盟，以加速開發新的基因編輯工具和療法。此外，各公司正在透過探索傳統醫療保健和農業以外的應用（例如工業生物技術和環境應用）來實現產品多樣化，以獲得競爭優勢。隨著基於 CRISPR 的療法和農產品獲得越來越多的監管批准，市場參與者正在為新興市場的長期成長做好準備，這在應對多樣化的監管環境中既帶來了機遇，也帶來了挑戰。整體而言，競爭非常激烈，競爭的驅動力是技術進步、創新和策略性業務擴張。

最新動態：

  • 2024年4月，Cellistic成功從Artisan Bio收購了STAR-CRISPR Cas-12基因編輯技術平台及其全部智慧財產權組合，增強了其在基於iPSC的同種異體細胞治療方面的能力。此次收購鞏固了 Cellistic 在基因編輯領域的領先地位，為細胞治療開發提供了高精度和高效率，並且能夠實現比傳統 CRISPR 技術更精確的客製化編輯。
  • 2024 年 7 月，Ncardia 收購了 STAR-CRISPR 技術，以增強誘導多能幹細胞 (iPSC) 中的基因編輯，從而實現高效率的基因敲入和敲除，同時最大程度地減少脫靶效應。此次收購透過提供更準確的疾病模型和先進的細胞療法增強了他們在藥物研發和再生醫學方面的能力。
  • 2024 年 3 月，理光與 ERS ​​Genomics 達成許可協議，以在美國和日本使用 CRISPR/Cas9 基因組編輯技術。此次合作加上理光對 Elixirgen Scientific 的收購，旨在利用 CRISPR 創建可靠的疾病模型，縮短藥物開發時間並提高成功率，從而加速藥物發現、個人化醫療和再生醫學。

目錄

第 1 章：CRISPR 和 Cas 基因市場概述

  • 研究範圍
  • 市場估計年限

第 2 章：執行摘要

  • 市場片段
    • CRISPR 和 Cas 基因市場產品摘要
    • CRISPR 和 Cas 基因市場片段（按應用）
    • CRISPR 和 Cas 基因市場片段（按最終用戶）
    • CRISPR 和 Cas 基因市場片段（按國家/地區）
    • CRISPR 和 Cas 基因市場片段（按地區）
  • 競爭洞察

第 3 章：CRISPR 和 Cas 基因關鍵市場趨勢

  • CRISPR 和 Cas 基因市場促進因素
    • 市場促進因素的影響分析
  • CRISPR 和 Cas 基因市場限制
    • 市場限制的影響分析
  • CRISPR 和 Cas 基因市場機會
  • CRISPR 和 Cas 基因市場未來趨勢

第 4 章：CRISPR 和 Cas 基因產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景規劃
  • 規範架構分析

第 5 章：CRISPR 與 Cas 基因市場：地緣政治緊張局勢升級的影響

  • 新冠肺炎疫情的影響
  • 俄烏戰爭的影響
  • 中東衝突的影響

第 6 章：CRISPR 和 Cas 基因市場模式

  • 2024 年 CRISPR 和 Cas 基因市場佔有率分析
  • 按主要製造商分類的細分數據
    • 成熟玩家分析
    • 新興企業分析

第 7 章：CRISPR 和 Cas 基因市場 - 按產品

  • 概述
    • 按產品細分的佔有率分析
    • CRISPR 產品
    • CRISPR 服務

第 8 章：CRISPR 和 Cas 基因市場 - 按應用

  • 概述
    • 按應用細分市場佔有率分析
    • 生物醫學應用
    • 農業應用
    • 工業應用

第 9 章：CRISPR 和 Cas 基因市場 - 按最終用戶

  • 概述
    • 按最終用戶分類的細分市場佔有率分析
    • 製藥和生物技術公司
    • 學術及研究機構
    • 合約研究組織

第 10 章：CRISPR 和 Cas 基因市場 - 按地區分類

  • 介紹
    • 按地區分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美 CRISPR 和 Cas 基因關鍵製造商
    • 北美市場規模及預測（按國家/地區）
    • 北美市場規模及預測（按產品分類）
    • 北美市場規模與預測，按應用分類
    • 北美市場規模及預測（按最終用戶）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲 CRISPR 和 Cas 基因關鍵製造商
    • 歐洲市場規模及預測（按國家）
    • 歐洲市場規模及預測（依產品分類）
    • 歐洲市場規模和預測，按應用
    • 歐洲市場規模及預測（按最終用戶）
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 瑞典
    • 俄羅斯
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區 CRISPR 和 Cas 基因關鍵製造商
    • 亞太地區市場規模及預測（依國家/地區分類）
    • 亞太地區市場規模及預測（依產品分類）
    • 亞太地區市場規模及預測（按應用分類）
    • 亞太地區市場規模及預測（依最終用戶）
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲 (LATAM)
    • 概述
    • 拉丁美洲的 CRISPR 和 Cas 基因關鍵製造商
    • 拉丁美洲市場規模及預測（按國家/地區）
    • 拉丁美洲市場規模及預測（按產品分類）
    • 拉丁美洲市場規模及預測（按應用分類）
    • 拉丁美洲市場規模及預測（按最終用戶）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲 (MEA)
    • 概述
    • 中東和非洲的 CRISPR 和 Cas 基因關鍵製造商
    • MEA 市場規模及預測（依國家/地區分類）
    • MEA 市場規模及預測（依產品分類）
    • MEA 市場規模及預測（按應用）
    • MEA 市場規模及預測（依最終用戶）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 其他地區

第 11 章：主要供應商分析- CRISPR 和 Cas 基因產業

  • 競爭儀錶板
    • Competitive Benchmarking
    • Competitive Positioning
  • 公司簡介
    • Thermo Fisher Scientific
    • Editas Medicine
    • CRISPR Therapeutics
    • Intellia Therapeutics
    • Caribou Biosciences
    • Horizon Discovery
    • Synthego Corporation
    • Agilent Technologies
    • GenScript Biotech
    • Takara Bio
    • Promega Corporation
    • MilliporeSigma
    • Bio-Rad Laboratories
    • New England Biolabs
    • Beam Therapeutics
    • Others

第 12 章：360 度分析師視角

第 13 章：附錄

  • 研究方法
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
簡介目錄
Product Code: ANV4717

REPORT HIGHLIGHT

CRISPR and Cas Gene Market size was valued at US$ 4,899.43 Million in 2024, expanding at a CAGR of 16.90% from 2025 to 2032.

CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) and Cas (CRISPR-associated) Genes form a groundbreaking gene-editing technology that allows precise alterations in DNA sequences. CRISPR acts as a natural immune defense mechanism in bacteria, while Cas proteins (such as Cas9) serve as molecular scissors guided by RNA to cut specific DNA strands. This system's ability to edit genes with unmatched accuracy has revolutionized genetic research and therapeutic development. The need for CRISPR-Cas technology stems from its potential to address genetic disorders by directly modifying faulty genes. Unlike traditional gene therapies, CRISPR is faster, cost-effective, and more precise, making it a superior choice for treating inherited diseases. It plays a pivotal role in personalized medicine, where tailored genetic interventions offer targeted treatment. Moreover, in agriculture, CRISPR enhances crop yields, pest resistance, and nutritional content, improving global food security. CRISPR's importance lies in its vast applications across healthcare, agriculture, and scientific research. It offers hope for curing genetic diseases like cystic fibrosis and sickle cell anemia, drives innovation in cancer immunotherapy, and aids in developing new antiviral treatments. Additionally, it empowers fundamental biological research by enabling detailed studies of gene functions. CRISPR-Cas technology continues to reshape science, holding transformative potential for human health and sustainability.

CRISPR and Cas Gene Market- Market Dynamics

Rising demand for precise gene-editing tools in healthcare and agriculture

The demand for precise gene-editing tools like CRISPR-Cas systems is surging in healthcare and agriculture due to their transformative potential and cost-effectiveness. In healthcare, CRISPR enables groundbreaking therapies for genetic disorders by directly correcting disease-causing mutations. For instance, it has shown promising results in treating sickle cell anemia and beta-thalassemia. Additionally, the technology is pivotal in cancer immunotherapy, where engineered T cells target specific tumor cells, advancing personalized medicine. The global rise in genetic disorders, affecting millions, is a key driver for adopting CRISPR technology in therapeutic research. According to the World Health Organization (WHO), approximately 10,000 monogenic diseases can potentially be treated through gene-editing advancements. In agriculture, CRISPR is redefining crop engineering, allowing scientists to develop pest-resistant, drought-tolerant, and nutritionally enhanced crops to combat food insecurity. It supports sustainable farming by reducing dependence on chemical pesticides and fertilizers. The U.S. Department of Agriculture (USDA) reported in 2023 that gene-edited crops could boost food production by up to 30% over the next decade, emphasizing the technology's potential to address global agricultural challenges. The rising adoption of CRISPR across these sectors is driven by its precision, efficiency, and affordability compared to older techniques like ZFNs and TALENs, making it a game-changer in both medicine and food production.

CRISPR and Cas Gene Market- Key Insights

  • As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 16.90% over the forecast period (2025-2032)
  • Based on Product segmentation, CRISPR Products was predicted to show maximum market share in the year 2024
  • Based on End-User segmentation, Pharmaceutical and Biotechnology Companies was the leading segment in 2024
  • On the basis of region, North America was the leading revenue generator in 2024

CRISPR and Cas Gene Market- Segmentation Analysis:

The Global CRISPR and Cas Gene Market is segmented on the basis of Product, Application, End-User, and Region.

The market is divided into two categories based on Product: CRISPR Products, and CRISPR Services. CRISPR Products dominate the market due to their widespread application in gene editing, research, and therapeutic development, offering unmatched precision and efficiency. The availability of user-friendly kits, reagents, and advanced Cas proteins has driven rapid adoption across healthcare, agriculture, and biotechnology industries.

The market is divided into three categories based on End-User: Pharmaceutical and Biotechnology Companies, Academic and Research Institutions, and Contract Research Organizations. Pharmaceutical and Biotechnology Companies dominate the market due to their extensive investments in gene-editing technologies for drug discovery, genetic disease therapies, and personalized medicine development. Their robust research infrastructure and focus on clinical trials accelerate the commercialization of innovative CRISPR-based solutions, driving market growth.

CRISPR and Cas Gene Market- Geographical Insights:

The CRISPR and Cas gene market exhibits significant regional variations driven by differences in technological advancements, research funding, regulatory frameworks, and market adoption. North America leads the global market, attributed to substantial investments in gene-editing technologies, a robust biotechnology industry, and supportive government policies. The United States, in particular, dominates due to extensive research initiatives and collaborations between leading pharmaceutical companies and research institutions. According to the National Institutes of Health (NIH), the U.S. government allocated over $1 billion in funding for CRISPR-related research projects in recent years. Europe holds a prominent market share, driven by strong academic research infrastructure and rising adoption of CRISPR technologies in therapeutic applications. Countries like Germany, the United Kingdom, and France are at the forefront of CRISPR innovations, particularly in agricultural biotechnology and precision medicine. However, regulatory constraints around genetic modifications remain a challenge. Asia-Pacific is experiencing rapid growth, primarily fueled by expanding biotechnology industries in countries like China, Japan, and South Korea. China has emerged as a major player, with aggressive investments in gene-editing research and clinical applications, especially in agriculture and disease treatment. The region's rising focus on food security and personalized medicine further accelerates demand. Emerging markets in Latin America and the Middle East & Africa are gradually adopting CRISPR technologies, driven by agricultural advancements and healthcare modernization.

CRISPR and Cas Gene Market- Competitive Landscape:

The CRISPR and Cas gene market is highly competitive, with a mix of established players and emerging biotech firms driving innovation across various applications. Companies in the market are focusing on developing advanced CRISPR-based products, such as gene-editing kits, reagents, and CRISPR-related services, to cater to the increasing demand from the pharmaceutical, biotechnology, and agricultural sectors. These companies invest heavily in research and development to enhance the precision, efficiency, and scalability of CRISPR technology, which is vital for successful commercialization. The competitive landscape is characterized by strategic partnerships, collaborations, and acquisitions aimed at expanding product portfolios and market reach. Key players are also engaging in alliances with academic institutions and research organizations to accelerate the development of new gene-editing tools and therapies. In addition, companies are diversifying their offerings by exploring applications beyond traditional healthcare and agriculture, such as industrial biotechnology and environmental applications, to gain a competitive edge. With growing regulatory approval for CRISPR-based therapies and agriculture products, market players are positioning themselves for long-term growth in emerging markets, which presents both opportunities and challenges in navigating diverse regulatory environments. Overall, the competition is intense, driven by technological advancements, innovation, and strategic business expansion.

Recent Developments:

  • In April 2024, Cellistic successfully acquired the STAR-CRISPR Cas-12 gene-editing technology platform and its full intellectual property portfolio from Artisan Bio, enhancing its capabilities in iPSC-based allogeneic cell therapy. This acquisition strengthens Cellistic's position as a leader in gene editing, offering high precision and efficiency in cell therapy development, and allows for custom edits with greater precision than conventional CRISPR technologies.
  • In July 2024, Ncardia acquired STAR-CRISPR technology to enhance gene editing in induced pluripotent stem cells (iPSCs), offering high efficiency in gene knock-ins and knock-outs with minimal off-target effects. This acquisition strengthens their capabilities in drug discovery and regenerative medicine by providing more accurate disease models and advanced cell therapies.
  • In March 2024, Ricoh entered a licensing agreement with ERS Genomics for access to CRISPR/Cas9 genome editing technology in the USA and Japan. This collaboration, combined with Ricoh's acquisition of Elixirgen Scientific, aims to accelerate drug discovery, personalized medicine, and regenerative medicine by leveraging CRISPR to create reliable disease models, improving drug development timelines and success rates.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL CRISPR AND CAS GENE MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Thermo Fisher Scientific
  • Editas Medicine
  • CRISPR Therapeutics
  • Intellia Therapeutics
  • Caribou Biosciences
  • Horizon Discovery
  • Synthego Corporation
  • Agilent Technologies
  • GenScript Biotech
  • Takara Bio
  • Promega Corporation
  • MilliporeSigma
  • Bio-Rad Laboratories
  • New England Biolabs
  • Beam Therapeutics
  • Others

GLOBAL CRISPR AND CAS GENE MARKET, BY PRODUCT- MARKET ANALYSIS, 2019 - 2032

  • CRISPR Products
  • CRISPR Services

GLOBAL CRISPR AND CAS GENE MARKET, BY APPLICATION - MARKET ANALYSIS, 2019 - 2032

  • Biomedical Applications
  • Agricultural Applications
  • Industrial Applications

GLOBAL CRISPR AND CAS GENE MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Pharmaceutical and Biotechnology Companies
  • Academic and Research Institutions
  • Contract Research Organizations

GLOBAL CRISPR AND CAS GENE MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. CRISPR and Cas Gene Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. CRISPR and Cas Gene Market Snippet by Product
    • 2.1.2. CRISPR and Cas Gene Market Snippet by Application
    • 2.1.3. CRISPR and Cas Gene Market Snippet by End-User
    • 2.1.4. CRISPR and Cas Gene Market Snippet by Country
    • 2.1.5. CRISPR and Cas Gene Market Snippet by Region
  • 2.2. Competitive Insights

3. CRISPR and Cas Gene Key Market Trends

  • 3.1. CRISPR and Cas Gene Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. CRISPR and Cas Gene Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. CRISPR and Cas Gene Market Opportunities
  • 3.4. CRISPR and Cas Gene Market Future Trends

4. CRISPR and Cas Gene Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. CRISPR and Cas Gene Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. CRISPR and Cas Gene Market Landscape

  • 6.1. CRISPR and Cas Gene Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. CRISPR and Cas Gene Market - By Product

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product, 2024 & 2032 (%)
    • 7.1.2. CRISPR Products
    • 7.1.3. CRISPR Services

8. CRISPR and Cas Gene Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 8.1.2. Biomedical Applications
    • 8.1.3. Agricultural Applications
    • 8.1.4. Industrial Applications

9. CRISPR and Cas Gene Market - By End-User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End-User, 2024 & 2032 (%)
    • 9.1.2. Pharmaceutical and Biotechnology Companies
    • 9.1.3. Academic and Research Institutions
    • 9.1.4. Contract Research Organizations

10. CRISPR and Cas Gene Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. CRISPR and Cas Gene Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. CRISPR and Cas Gene Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.8. UK
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. UK Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.8.4. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.8.5. UK Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.9. France
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. France Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.9.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.9.5. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.10. Italy
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. Italy Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.10.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.10.5. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.11. Spain
      • 10.3.11.1. Overview
      • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.3. Spain Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.11.5. Spain Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.12. The Netherlands
      • 10.3.12.1. Overview
      • 10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.3. The Netherlands Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.12.4. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.12.5. The Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Overview
      • 10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.13.5. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.14. Russia
      • 10.3.14.1. Overview
      • 10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.3. Russia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.14.5. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.15. Poland
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Poland Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.16. Rest of Europe
      • 10.3.16.1. Overview
      • 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.16.3. Rest of the Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.16.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.16.5. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. CRISPR and Cas Gene Key Manufacturers in Asia Pacific
    • 10.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.4.5. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.6. APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.7. China
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. China Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.7.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.7.5. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.8. India
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. India Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.8.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.8.5. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.12. Indonesia
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Indonesia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.13. Thailand
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Thailand Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.5. Latin America (LATAM)
    • 10.5.1. Overview
    • 10.5.2. CRISPR and Cas Gene Key Manufacturers in Latin America
    • 10.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.5.5. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.6. LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa (MEA)
    • 10.6.1. Overview
    • 10.6.2. CRISPR and Cas Gene Key Manufacturers in Middle East and Africa
    • 10.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.6.5. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.6. MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.8. UAE
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. UAE Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.8.4. UAE Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.8.5. UAE Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- CRISPR and Cas Gene Industry

  • 11.1. Competitive Dashboard
    • 11.1.1. Competitive Benchmarking
    • 11.1.2. Competitive Positioning
  • 11.2. Company Profiles
    • 11.2.1. Thermo Fisher Scientific
    • 11.2.2. Editas Medicine
    • 11.2.3. CRISPR Therapeutics
    • 11.2.4. Intellia Therapeutics
    • 11.2.5. Caribou Biosciences
    • 11.2.6. Horizon Discovery
    • 11.2.7. Synthego Corporation
    • 11.2.8. Agilent Technologies
    • 11.2.9. GenScript Biotech
    • 11.2.10. Takara Bio
    • 11.2.11. Promega Corporation
    • 11.2.12. MilliporeSigma
    • 11.2.13. Bio-Rad Laboratories
    • 11.2.14. New England Biolabs
    • 11.2.15. Beam Therapeutics
    • 11.2.16. Others

12. 360 Degree AnalystView

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us